Helen Poulson

Helen Poulson

Hogan Lovells

Contact
View Bio
RSS

Latest Posts › Pharmaceutical Patents

Share:

Court of Appeal hands down reasons for awarding AZ an interim injunction in the UK against Glenmark’s generic dapagliflozin for...

Just under two weeks ago, we reported the Court of Appeal had awarded AstraZeneca (AZ) a preliminary injunction in the UK against Glenmark’s generic dapagliflozin (dapa) product for type II diabetes, until the hearing...more

4/24/2025  /  Appeals , Generic Drugs , Intellectual Property Litigation , Litigation Strategies , Patent Litigation , Patent Validity , Pharmaceutical Industry , Pharmaceutical Patents , Preliminary Injunctions , UK

UK Court of Appeal grants AstraZeneca an interim injunction against Glenmark’s generic dapagliflozin for type II diabetes

In a reversal of fortune, yesterday (9 April) the UK Court of Appeal awarded AstraZeneca (AZ) an interim injunction keeping Glenmark’s dapagliflozin (dapa) off the UK market until the form of order hearing in the parallel...more

4/11/2025  /  Appeals , Generic Drugs , Intellectual Property Litigation , Patent Litigation , Patent Validity , Pharmaceutical Industry , Pharmaceutical Patents , Preliminary Injunctions , Reversal , UK
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide